Page last updated: 2024-10-23

benzamide and Lung Neoplasms

benzamide has been researched along with Lung Neoplasms in 2 studies

benzamide : An aromatic amide that consists of benzene bearing a single carboxamido substituent. The parent of the class of benzamides.

Lung Neoplasms: Tumors or cancer of the LUNG.

Research Excerpts

ExcerptRelevanceReference
" We wish to disclose the discovery of a macrocycle which showed impressive biomarker activity 24-h post dosing and which demonstrated prolonged exposure in tumors."1.37Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model. ( Bloom, JD; Boschelli, F; Dushin, RG; Golas, JM; Johnson, M; Levin, JI; Li, Z; Liu, H; Lucas, J; Nikitenko, A; Nittoli, T; Olland, A; Otteng, M; Vogan, E; Zapf, CW, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jung, SY1
Kho, S1
Song, KH1
Ahn, J1
Park, IC1
Nam, KY1
Hwang, SG1
Nam, SY1
Cho, SJ1
Song, JY1
Zapf, CW1
Bloom, JD1
Li, Z1
Dushin, RG1
Nittoli, T1
Otteng, M1
Nikitenko, A1
Golas, JM1
Liu, H1
Lucas, J1
Boschelli, F1
Vogan, E1
Olland, A1
Johnson, M1
Levin, JI1

Other Studies

2 other studies available for benzamide and Lung Neoplasms

ArticleYear
Novel focal adhesion kinase 1 inhibitor sensitizes lung cancer cells to radiation in a p53-independent manner.
    International journal of oncology, 2017, Volume: 51, Issue:5

    Topics: Animals; Apoptosis; Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mese

2017
Discovery of a stable macrocyclic o-aminobenzamide Hsp90 inhibitor which significantly decreases tumor volume in a mouse xenograft model.
    Bioorganic & medicinal chemistry letters, 2011, Aug-01, Volume: 21, Issue:15

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Benzamides; Binding Sites; Biomarkers; Drug Ev

2011